94053-6

LOINC 2.82

Mycobacterium tuberculosis complex resistance panel by Molecular genetics method

MTB cmplx resist Pnl Islt/Spm

Definition

  • This panel contains results for the detection of mutations in the various MTB complex genes that indicate resistance to first- and second-line anti-tuberculous medications, including isoniazid, rifampin, ethambutol, pyrazinamide, the fluoroquinolones (moxifloxacin and ofloxacin) and the aminoglycosides (streptomycin, kanamycin, and amikacin). The predicted susceptibility (resistant, susceptible) to various medications based on the variants identified may also be reported.

Component

  • Mycobacterium tuberculosis complex resistance panel

Specimen / system

  • Isolate/Specimen

Class

  • PANEL.ABXBACT

Property

  • -

Scale

  • -

Method

  • Molgen

Related names

  • Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; Compx; Islt; Islt/Spm; Isol; M tb; M TB Cmplx; M tuberculosis; Molecular genetics; Mtb; MTB cmplx resist Pnl; Myco; Mycobact; Mycobacterium tuberculosum; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec; TB; Tuberculosis

Index terms

  • Acid Fast
  • Acid Fast Bacilli
  • Acid fast bacillus
  • AFB
  • ANTIBIOTIC SUSCEPTIBILITIES
  • Compx
  • Islt
  • Islt/Spm
  • Isol
  • M tb
  • M TB Cmplx
  • M tuberculosis
  • Molecular genetics
  • Mtb
  • MTB cmplx resist Pnl
  • Myco
  • Mycobact
  • Mycobacterium tuberculosum
  • Pan
  • PANEL.ANTIBIOTIC SUSCEPTIBILITIES
  • Panl
  • PCR
  • Pnl
  • Point in time
  • Random
  • Resist
  • Resistanc
  • Resistant
  • Resistent
  • Spec
  • TB
  • Tuberculosis